Oct 28, 2026 09:15AM
Aug 12, 2026 04:46PM
Aug 11, 2026 09:05AM
Jul 13, 2026 07:06AM
Jun 5, 2026 04:04PM
May 20, 2026 04:06PM
May 13, 2026 04:41PM Longeveron (LGVN) Misses Q1 EPS by 19c
May 11, 2026 07:44AM
May 4, 2026 07:34AM
Apr 10, 2026 04:05PM
Apr 8, 2026 09:15AM
Feb 25, 2026 11:05AM
Jan 29, 2026 09:15AM
Dec 2, 2025 09:15AM Longeveron receives Canadian patent for stem cell treatments
Dec 1, 2025 12:02PM
Nov 19, 2025 09:15AM
Nov 5, 2025 06:24AM
Nov 5, 2025 06:21AM
Sep 3, 2025 04:05PM
Jul 21, 2025 09:15AM
Jul 8, 2025 09:15AM Longeveron gets FDA approval for pediatric heart disease trial
Jun 26, 2025 09:05AM
Jun 24, 2025 06:31AM
May 8, 2025 07:22PM
Apr 22, 2025 04:06PM
Mar 28, 2025 04:09PM
Mar 20, 2025 09:00AM
Mar 11, 2025 08:31AM Longeveron (LGVN) Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel in Alzheimer’s Disease
Feb 28, 2025 04:04PM
Feb 18, 2025 09:26AM
Jan 30, 2025 05:39PM
Nov 25, 2024 06:53AM
Nov 11, 2024 09:06AM
Oct 29, 2024 10:03AM
Sep 4, 2024 07:25AM H.C. Wainwright Reiterates Buy Rating on Longeveron (LGVN)
Sep 3, 2024 09:02AM
Jul 29, 2024 06:53AM
Jul 18, 2024 08:45AM
Jul 17, 2024 08:01AM
Jul 10, 2024 07:31AM
Jul 9, 2024 09:01AM
Jun 28, 2024 04:19PM Longeveron (LGVN) Files for 3.56M Share Offering by Selling Stockholders
Jun 17, 2024 08:39AM
Jun 11, 2024 09:01AM

474,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All